1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, August 2016 (p8)

Biological Therapy Analysis & Statistics, August 2016 (p8)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

211-240 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Aplastic Anemia Global Clinical Trials Review, H2, 2016

Aplastic Anemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Aplastic Anemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Aplastic Anemia clinical ...

  • Industries : Pathology, Cancer, Drug Discovery and Development, Pharmaceutical, Healthcare
  • Countries : World
Fanconi Anemia Global Clinical Trials Review, H2, 2016

Fanconi Anemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Fanconi Anemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Fanconi Anemia clinical ...

  • Industries : Pathology, Drug Discovery and Development, Healthcare
  • Countries : World
Cystic Fibrosis Global Clinical Trials Review, H2, 2016

Cystic Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Cystic Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystic Fibrosis clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology
  • Countries : World
Sepsis Global Clinical Trials Review, H2, 2016

Sepsis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Sepsis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2016" provides an overview of Sepsis clinical trials scenario. This ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Neutropenia Global Clinical Trials Review, H2, 2016

Neutropenia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Neutropenia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Neutropenia clinical trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : World
Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Cancer, Biotechnology, Biological Therapy
  • Countries : World
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Chronic Disease, Pathology, Therapy
  • Countries : World
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Burns - Pipeline Review, H2 2016

Burns - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Burns - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Burns - Pipeline Review, H2 2016’, provides an overview of the Burns pipeline landscape. The report provides comprehensive information ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World, Europe
Myocardial Ischemia - Pipeline Review, H2 2016

Myocardial Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Myocardial Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2016’, provides an overview of the Myocardial Ischemia pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Russian Federation
Dystrophin (DMD) - Pipeline Review, H2 2016

Dystrophin (DMD) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dystrophin (DMD) - Pipeline Review, H2 2016’, provides in depth analysis on Dystrophin (DMD) targeted pipeline therapeutics. ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States, World
Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Bone Marrow Transplant Rejection - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H2 2016

Grass Pollen Allergy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Grass Pollen Allergy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2016’, provides an overview of the Grass Pollen Allergy pipeline landscape. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2016’, provides an overview of the Alpha- Antitrypsin ...

  • Industries : Biotechnology, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Nasopharyngeal Cancer - Pipeline Review, H2 2016

Nasopharyngeal Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Nasopharyngeal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2016’, provides an overview of the Nasopharyngeal Cancer pipeline landscape. ...

  • Industries : Cancer, Pathology
  • Countries : United States
Myocarditis - Pipeline Review, H2 2016

Myocarditis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Myocarditis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocarditis - Pipeline Review, H2 2016’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, World
Batten Disease - Pipeline Review, H2 2016

Batten Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Batten Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2016’, provides an overview of the Batten Disease pipeline landscape. The report provides ...

  • Industries : Mental Health, Pathology
  • Countries : United States
US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US Cell Surface Marker Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 1450
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Global Cell Surface Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

Global Cell Surface Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 3500
  • Industry report
  • August 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Cancer, Pathology, Biological Therapy
  • Countries : World
Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology, Therapy
  • Countries : World
T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World, United States
T-Cell Leukemia Global Clinical Trials Review, H2, 2016

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

T-Cell Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Biological Therapy, Cancer
  • Countries : World
About 2800 reports

Download Unlimited Documents from Trusted Public Sources

Medigene AG - Investor Report, December 2016

  • December 2016
    39 pages
  • Immunotherapy  

    Cell Therapy  

  • Germany  

View report >

Filgrastim Industry

December 2016

Microrna Industry

November 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.